Cite
HARVARD Citation
Glatt, S. et al. (2019). Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study. Annals of the rheumatic diseases. 78 (8), pp. 1033-. [Online].